JP2008500317A - 抗菌剤としての3−’4−{6−置換アルカノイル)ピリジン−3−イル}−3−フェニル−5−(1h−1,2,3−トリアゾール−1−イルメチル)−1,3−オキサゾリジン−2−オン - Google Patents

抗菌剤としての3−’4−{6−置換アルカノイル)ピリジン−3−イル}−3−フェニル−5−(1h−1,2,3−トリアゾール−1−イルメチル)−1,3−オキサゾリジン−2−オン Download PDF

Info

Publication number
JP2008500317A
JP2008500317A JP2007514087A JP2007514087A JP2008500317A JP 2008500317 A JP2008500317 A JP 2008500317A JP 2007514087 A JP2007514087 A JP 2007514087A JP 2007514087 A JP2007514087 A JP 2007514087A JP 2008500317 A JP2008500317 A JP 2008500317A
Authority
JP
Japan
Prior art keywords
compound
formula
mmol
alkyl
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007514087A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008500317A5 (enExample
Inventor
グレイブストック,マイケル・バリー
レック,フォルカート
ジョウ,フェイ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0411593A external-priority patent/GB0411593D0/en
Priority claimed from GB0500054A external-priority patent/GB0500054D0/en
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of JP2008500317A publication Critical patent/JP2008500317A/ja
Publication of JP2008500317A5 publication Critical patent/JP2008500317A5/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2007514087A 2004-05-25 2005-05-24 抗菌剤としての3−’4−{6−置換アルカノイル)ピリジン−3−イル}−3−フェニル−5−(1h−1,2,3−トリアゾール−1−イルメチル)−1,3−オキサゾリジン−2−オン Pending JP2008500317A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0411593A GB0411593D0 (en) 2004-05-25 2004-05-25 Chemical compounds
GB0500054A GB0500054D0 (en) 2005-01-05 2005-01-05 Chemical compounds
PCT/GB2005/002051 WO2005116022A1 (en) 2004-05-25 2005-05-24 3- `4- {6-substituted alkanoyl) pyridin-3-yl} -3-phenyl! -5- (1h-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents

Publications (2)

Publication Number Publication Date
JP2008500317A true JP2008500317A (ja) 2008-01-10
JP2008500317A5 JP2008500317A5 (enExample) 2008-06-26

Family

ID=34968778

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007514087A Pending JP2008500317A (ja) 2004-05-25 2005-05-24 抗菌剤としての3−’4−{6−置換アルカノイル)ピリジン−3−イル}−3−フェニル−5−(1h−1,2,3−トリアゾール−1−イルメチル)−1,3−オキサゾリジン−2−オン

Country Status (10)

Country Link
US (1) US20080021012A1 (enExample)
EP (1) EP1753754A1 (enExample)
JP (1) JP2008500317A (enExample)
AU (1) AU2005247668A1 (enExample)
BR (1) BRPI0511526A (enExample)
CA (1) CA2566963A1 (enExample)
IL (1) IL179349A0 (enExample)
MX (1) MXPA06013537A (enExample)
NO (1) NO20065889L (enExample)
WO (1) WO2005116022A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
EP2346858B1 (en) * 2008-10-10 2019-08-07 Merck Sharp & Dohme Corp. Methods for preparing oxazolidinones and compositions containing them
UA114068C2 (xx) 2009-02-03 2017-04-25 Кристалічні частинки (r)-3-(4-(2-(2-метилтетразол-5-іл)піридин-5-іл)-3-фторфеніл)-5-гідроксиметилоксазолідин-2-ондиводеньфосфату
US8580767B2 (en) * 2009-05-28 2013-11-12 Trius Therapeutics, Inc. Oxazolidinone containing dimer compounds, compositions and methods to make and use
KR101561964B1 (ko) 2013-11-15 2015-10-20 한국과학기술연구원 옥사졸리디논 화합물 및 이를 포함하는 c형 간염 예방 또는 치료용 약학 조성물
JP6864379B2 (ja) 2016-03-31 2021-04-28 オンターナル セラピューティック インコーポレイテッドOncternal Therapeutics, Inc. インドール類似体及びその使用
US11555033B2 (en) 2020-06-18 2023-01-17 Akagera Medicines, Inc. Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003072575A1 (en) * 2002-02-28 2003-09-04 Astrazeneca Ab 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents
JP2003531211A (ja) * 2000-04-25 2003-10-21 アストラゼネカ アクチボラグ 抗生物質活性を持つオキサジリジノン誘導体
JP2003535860A (ja) * 2000-06-05 2003-12-02 ドン・ア・ファーム・カンパニー・リミテッド 新規なオキサゾリジノン誘導体及びその製造方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003531211A (ja) * 2000-04-25 2003-10-21 アストラゼネカ アクチボラグ 抗生物質活性を持つオキサジリジノン誘導体
JP2003535860A (ja) * 2000-06-05 2003-12-02 ドン・ア・ファーム・カンパニー・リミテッド 新規なオキサゾリジノン誘導体及びその製造方法
WO2003072575A1 (en) * 2002-02-28 2003-09-04 Astrazeneca Ab 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents

Also Published As

Publication number Publication date
NO20065889L (no) 2007-02-20
MXPA06013537A (es) 2007-01-26
BRPI0511526A (pt) 2007-12-26
IL179349A0 (en) 2007-03-08
WO2005116022A1 (en) 2005-12-08
US20080021012A1 (en) 2008-01-24
AU2005247668A1 (en) 2005-12-08
EP1753754A1 (en) 2007-02-21
CA2566963A1 (en) 2005-12-08

Similar Documents

Publication Publication Date Title
US20060058317A1 (en) Oxazolidinone derivatives as antibacterial
JP2006519247A (ja) 抗生物質として有用なヒドロキシメチル置換ジヒドロイソオキサゾール誘導体
JP2006515601A (ja) 抗細菌性薬剤としてのオキサゾリジノン
JP2006512352A (ja) オキサゾリジノン誘導体及び抗菌薬としてのそれらの使用
JP2008500318A (ja) 抗菌剤としての3−{4−(ピリジン−3−イル)フェニル}−5−(1h−1,2,3−トリアゾール−1−イルメチル)−1,3−オキサゾリジン−2−オン
WO2003072576A2 (en) Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them
US20060052399A1 (en) Oxazolidinone derivatives as antibacterial agents
US20080064689A1 (en) 3-[4-(6-Pyridin-3-Yl)-3-Phenyl] -5-(1H-1,2,3-Triazol-1-Ylmethyl)-1,3-Oxazolidin-2-Ones as Antibacterial Agents
MXPA06013540A (es) Derivados de 3-(4-(2 -dihidroisoxasol -3-ilpiridin-5-il) fenil)-5- triazol-1- ilmetiloxazolidin -2-ona como inhibidores de mao para el tratamiento de infecciones bacterianas.
JP2008500317A (ja) 抗菌剤としての3−’4−{6−置換アルカノイル)ピリジン−3−イル}−3−フェニル−5−(1h−1,2,3−トリアゾール−1−イルメチル)−1,3−オキサゾリジン−2−オン
US7157482B2 (en) Antibacterial 1,3-oxazolidin-2-one derivatives
JP2006515286A (ja) 抗細菌性化合物
JP2006514647A (ja) 抗菌性オキサゾリジノン類
JP2006520775A (ja) 抗菌性オキサリジノン類
CN1989134A (zh) 作为抗菌剂的3-{4-(吡啶-3-基)苯基}-5-(1h-1,2,3-三唑-1-基甲基)-1,3-唑烷-2-酮类
CN1989135A (zh) 作为mao抑制剂用于治疗细菌感染的3-(4-(2-二氢异唑-3-基吡啶-5-基)苯基)-5-三唑-1-基甲基唑烷-2-酮衍生物
KR20070023766A (ko) 항박테리아제로서의 3-[4-{6-(치환알카노일)피리딘-3-일}-3-페닐]-5-(1h-1,2,3-트리아졸-1-일메틸)-1,3-옥사졸리딘-2-온
CN1989137A (zh) 作为抗菌剂的3-4-{6-(取代的烷酰基)吡啶-3-基}-3-苯基-5-(1h-1,2,3-三唑-1-基甲基)-1,3-唑烷-2-酮类
KR20070023765A (ko) 항박테리아제로서의3-{4-(피리딘-3-일)페닐}-5-(1h-1,2,3-트리아졸-1-일메틸)-1,3-옥사졸리딘-2-온
KR20070022784A (ko) 박테리아 감염의 치료를 위한 mao 억제제로서의3-(4-(2-디히드로이속사졸-3-일피리딘-5-일)페닐)-5-트리아졸-1-일메틸옥사졸리딘-2-온 유도체

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080502

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080502

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20110803

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110913

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120402